Drugs / 2PX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00804375 | Dec 2008 → Jun 2010 | — | Smerud Medical Research International AS | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2PX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00804375 ↗ |
| Known as | Strontium Chloride Hexahydrate | “topical 2PX (Strontium Chloride Hexahydrate)” NCT00804375 ↗ |
| Route | Topical | “cutaneous solution to be applied twice daily for 84 days” NCT00804375 ↗ |